Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Benzer Materyaller

• A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
  Yazar:: Cheadle, E J, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells
  Yazar:: Dovedi, Simon J., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity
  Yazar:: Gao, Dong, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity
  Yazar:: Manna, Saikat, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
  Yazar:: Dovedi, S J, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)